Advancing cancer diagnosis and therapy: MXene-based biosensing and nanomedicine applications.
3/5 보강
TL;DR
This article intends to address essential topics in MXene biosensing domains ranging from MXene special properties to the role of its functionalization and novel sensor applications across various cancers such as gastric, colorectal, colon, breast, pancreatic, oral, ovarian, lung, prostate, acute lymphocytic leukemia, chronic myelogenous leukemia, and neuroendocrine malignancies.
OpenAlex 토픽 ·
MXene and MAX Phase Materials
2D Materials and Applications
Advanced Sensor and Energy Harvesting Materials
This article intends to address essential topics in MXene biosensing domains ranging from MXene special properties to the role of its functionalization and novel sensor applications across various can
APA
Hesam Kamyab, Elham Khalili, et al. (2026). Advancing cancer diagnosis and therapy: MXene-based biosensing and nanomedicine applications.. International immunopharmacology, 176, 116464. https://doi.org/10.1016/j.intimp.2026.116464
MLA
Hesam Kamyab, et al.. "Advancing cancer diagnosis and therapy: MXene-based biosensing and nanomedicine applications.." International immunopharmacology, vol. 176, 2026, pp. 116464.
PMID
41797089 ↗
Abstract 한글 요약
Prognosis and timely cancer detection can alleviate the disease or improve its medical state. Utilization of nanostructures facilitates rapid cancer diagnosis and efficient therapy. MXenes are two-dimensional materials characterized by exceptional electrical conductivity, superior optical features, mechanical durability, and remarkable optical features. MXenes have diverse applications in nanobiomedicine, including biosensing, drug delivery, cancer therapy, and bioimaging, owing to their superior biocompatibility, large surface area, and favorable physicochemical properties. This paper intends to address essential topics in MXene biosensing domains ranging from MXene special properties to the role of its functionalization and novel sensor applications across various cancers such as gastric, colorectal, colon, breast, pancreatic, oral, ovarian, lung, prostate, acute lymphocytic leukemia, chronic myelogenous leukemia, and neuroendocrine malignancies, covering different biomarkers like MUC1, miRNA-122, CEA, HER2, CgA, CYFRA21-1, ALP, PSA, and exosomes as biomarker sources. It is hoped that this article will be useful to scientists in developing and conceptualizing new methods for designing biosensors to take a step towards detecting cancer biomarkers in early stages and subsequent eradication of malignancies.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.